These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9377931)

  • 1. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient.
    Arney KL; Tiernan R; Judson MA
    Chest; 1997 Oct; 112(4):1128-30. PubMed ID: 9377931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infection.
    Patterson TS; Barton LL; Shehab ZM; Hutter JJ
    Clin Pediatr (Phila); 1996 May; 35(5):257-60. PubMed ID: 8804544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex.
    Goldblum D; Frueh BE; Zimmerli S; Böhnke M
    Cornea; 2000 Nov; 19(6):853-6. PubMed ID: 11095064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM; Seibel NL; Walsh TJ
    Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABELCET treatment.
    Boyle JA; Swenson CE
    J Clin Pharmacol; 1999 Apr; 39(4):427-8. PubMed ID: 10197303
    [No Abstract]   [Full Text] [Related]  

  • 6. Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience.
    Lister J
    Eur J Haematol Suppl; 1996; 57():18-23. PubMed ID: 8706812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.
    Linden P; Williams P; Chan KM
    Clin Transplant; 2000 Aug; 14(4 Pt 1):329-39. PubMed ID: 10945204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient.
    Letscher-Bru V; Campos F; Waller J; Randriamahazaka R; Candolfi E; Herbrecht R
    J Clin Microbiol; 2002 Mar; 40(3):1100-2. PubMed ID: 11880452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient.
    Guinvarc'h A; Guilbert L; Marmorat-Khuong A; Lavarde V; Chevalier P; Amrein C; Guillemain R; Berrebi A
    Mycoses; 1998; 41(1-2):59-61. PubMed ID: 9610136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
    Crompton JA; Alexander D; Somerville T; Shihab FS
    Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, non-comparative evaluation of the efficacy and safety of amphotericin B lipid complex as treatment of neutropenic patients with presumed or confirmed pulmonary fungal infections.
    Myint H; Kyi AA; Winn RM
    J Antimicrob Chemother; 1998 Mar; 41(3):424-6. PubMed ID: 9578177
    [No Abstract]   [Full Text] [Related]  

  • 13. Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.
    Pappas PG
    Clin Infect Dis; 2005 May; 40 Suppl 6():S379-83. PubMed ID: 15809923
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid-based antifungal agents.
    Arikan S
    Cell Mol Biol Lett; 2002; 7(2):220-1. PubMed ID: 12097922
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
    Palmer SM; Drew RH; Whitehouse JD; Tapson VF; Davis RD; McConnell RR; Kanj SS; Perfect JR
    Transplantation; 2001 Aug; 72(3):545-8. PubMed ID: 11502995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
    Winston DJ; Schiller GJ
    Clin Infect Dis; 2000 Jan; 30(1):236-7. PubMed ID: 10619780
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH; Dodds Ashley E; Benjamin DK; Duane Davis R; Palmer SM; Perfect JR
    Transplantation; 2004 Jan; 77(2):232-7. PubMed ID: 14742987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria for use of amphotericin B lipid complex injections in adults and children.
    Am J Health Syst Pharm; 1996 Nov; 53(22):2751-2. PubMed ID: 9072180
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Perfect JR
    Clin Infect Dis; 2005 May; 40 Suppl 6():S401-8. PubMed ID: 15809926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
    Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.